Literature DB >> 29873959

Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study.

Frederikke Hordam Gronemann1, Martin B Jorgensen2, Merete Nordentoft2,3, Per K Andersen4, Merete Osler5,1,6.   

Abstract

OBJECTIVE: Varying definitions of treatment-resistant depression (TRD) across studies make it difficult to estimate the size of the problem and to identify patients at increased risk. The aim of this cohort study was to examine the incidence of TRD, disease-related risk factors, and changes over time using different definitions of TRD.
METHODS: From 1996 through 2014, all patients with a first-time hospital contact for depression (ICD-10 codes F32 and F33) were identified in Danish National Patient Registries. A total of 211,689 patients were followed for shifts in antidepressant treatment in the Danish Patient and Prescription Registries. TRD was defined at the second shift in treatment during the first 12 months after diagnosis. The associations of year and type of hospital contact, depression subtype, and severity of TRD were analyzed using Cox proportional hazard regression.
RESULTS: A total of 14.0% of patients experienced a second shift in antidepressant treatment during the first year after admission. When applying 3 other common TRD definitions, the proportion varied from 13% to 31%. Psychiatric inpatients and patients with recurrent or severe depression had the highest incidence of TRD. The incidence of TRD was also slightly higher in patients diagnosed after 2001. All associations were replicated when data were reanalyzed using the alternative definitions of TRD.
CONCLUSIONS: About 14% of patients with depression developed TRD during the first year after first hospital contact. The incidence was highest in patients with severe depression and was relatively stable over time. Various definitions of TRD provided different estimates of the frequency of TRD but were all associated with disease severity. © Copyright 2018 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2018        PMID: 29873959     DOI: 10.4088/JCP.17m11845

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Treatment-resistant depression and labor market affiliation in the Danish welfare society: a register-based study.

Authors:  Frederikke Hørdam Gronemann; Thomas Lund; Louise Lindholdt; Kathrine Bang Madsen; Martin Balslev Jørgensen; Merete Nordentoft; Merete Osler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-02-08       Impact factor: 4.328

2.  Structural and biochemical imaging reveals systemic LPS-induced changes in the rat brain.

Authors:  Michael Fritz; Anna M Klawonn; Qingyu Zhao; Edith V Sullivan; Natalie M Zahr; Adolf Pfefferbaum
Journal:  J Neuroimmunol       Date:  2020-08-26       Impact factor: 3.478

3.  Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017.

Authors:  Johanna Seifert; Hannah B Maier; Fabienne Führmann; Stefan Bleich; Susanne Stübner; Marcel Sieberer; Xueqiong Bernegger; Waldemar Greil; Cornelius Schüle; Sermin Toto; Renate Grohmann; Matthias A Reinhard
Journal:  J Neural Transm (Vienna)       Date:  2022-05-07       Impact factor: 3.850

4.  Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.

Authors:  Philip Brenner; Lena Brandt; Gang Li; Allitia DiBernardo; Robert Bodén; Johan Reutfors
Journal:  Addiction       Date:  2019-04-15       Impact factor: 6.526

5.  Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis.

Authors:  Péter Döme; Péter Kunovszki; Péter Takács; László Fehér; Tamás Balázs; Károly Dede; Siobhán Mulhern-Haughey; Sébastien Barbreau; Zoltán Rihmer
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

6.  Excess deaths in treatment-resistant depression.

Authors:  Philip Brenner; Johan Reutfors; Michel Nijs; Therese M-L Andersson
Journal:  Ther Adv Psychopharmacol       Date:  2021-04-12

7.  Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment.

Authors:  Yuri E Rybak; Ka S P Lai; Rajamannar Ramasubbu; Fidel Vila-Rodriguez; Daniel M Blumberger; Peter Chan; Nicholas Delva; Peter Giacobbe; Caroline Gosselin; Sidney H Kennedy; Hani Iskandar; Shane McInerney; Paula Ravitz; Verinder Sharma; Ari Zaretsky; Amer M Burhan
Journal:  Depress Anxiety       Date:  2021-02-02       Impact factor: 6.505

8.  Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.

Authors:  Kristoffer Jarlov Jensen; Frederikke Hørdam Gronemann; Mikkel Zöllner Ankarfeldt; Espen Jimenez-Solem; Sarah Alulis; Jesper Riise; Nikolaj Bødker; Merete Osler; Janne Petersen
Journal:  PLoS One       Date:  2022-09-27       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.